title: Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.
abstract: ABSTRACT The chronic nature of tuberculosis (TB), its requirement of long duration of treatment, its ability to evade immune intervention, and its propensity to relapse after drug treatment is discontinued are reminiscent of other chronic, biofilm-associated bacterial diseases. Historically, Mycobacterium tuberculosis was grown as a pellicle, a biofilm-like structure, at the liquid-air interface in a variety of synthetic media. Notably, the most widely administered human vaccine, BCG, is grown as a pellicle for vaccine production. However, the molecular requirements for this growth remain ill defined. Here, we demonstrate that keto-mycolic acids (keto-MA) are essential for pellicle growth, and mutants lacking in or depleted of this MA species are unable to form a pellicle. We investigated the role of the pellicle biofilm in the reduction of antibiotic sensitivity known as drug tolerance using the pellicle-defective ΔmmaA4 mutant strain. We discovered that the ΔmmaA4 mutant, which is both pellicle defective and highly sensitive to rifampicin (RIF) under planktonic growth, when incorporated within the wild-type pellicle biofilm, was protected from the bactericidal activity of RIF. The observation that growth within the M. tuberculosis pellicle biofilm can confer drug tolerance to a drug-hypersensitive strain suggests that identifying molecular requirements for pellicle growth could lead to development of novel interventions against mycobacterial infections. Our findings also suggest that a class of drugs that can disrupt M. tuberculosis biofilm formation, when used in conjunction with conventional antibiotics, has the potential to overcome drug tolerance. IMPORTANCE Two of the most important questions in tuberculosis (TB) research are (i) how does Mycobacterium tuberculosis persist in the human host for decades in the face of an active immune response and (ii) why does it take six months and four drugs to treat uncomplicated TB. Both these aspects of M. tuberculosis biology are reminiscent of infections caused by organisms capable of forming biofilms. M. tuberculosis is capable of growing as a biofilm-like structure called the pellicle. In this study, we demonstrate that a specific cell wall component, keto-mycolic acid, is essential for pellicle growth. We also demonstrate that a strain of M. tuberculosis that is both drug sensitive and pellicle defective exhibits commensal behavior and becomes drug tolerant by becoming part of a heterogeneous pellicle, a characteristic of multispecies biofilms. These observations could have important implications for identifying novel pathways for M. tuberculosis drug tolerance and the design of new modalities to rapidly treat TB.
authors: Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
authors: Dhinakaran
authors: D
authors: Sambandan
authors: Dee N
authors: DN
authors: Dao
authors: Brian C
authors: BC
authors: Weinrick
authors: Catherine
authors: C
authors: Vilchèze
authors: Sudagar S
authors: SS
authors: Gurcha
authors: Anil
authors: A
authors: Ojha
authors: Laurent
authors: L
authors: Kremer
authors: Gurdyal S
authors: GS
authors: Besra
authors: Graham F
authors: GF
authors: Hatfull
authors: William R
authors: WR
authors: Jacobs
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development*; D004361:Drug Tolerance; D017353:Gene Deletion; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000502:physiology*; D009171:Mycolic Acids / Q000378:metabolism*
chemical_list: D000995:Antitubercular Agents; D001426:Bacterial Proteins; D009171:Mycolic Acids
references: FEMS Microbiol Lett. 2006 Apr;257(1):43-9
references: 16553830
references: PLoS Pathog. 2007 Apr;3(4):e57
references: 17447841
references: Biochim Biophys Acta. 1956 May;20(2):299-309
references: 13328853
references: Trends Microbiol. 2005 Jan;13(1):7-10
references: 15639625
references: J Exp Med. 1947 Jul 31;86(2):175-84
references: 19871665
references: PLoS Pathog. 2008 Jun 06;4(6):e1000081
references: 18535659
references: Trends Microbiol. 2001 Jan;9(1):34-9
references: 11166241
references: Microbiology (Reading). 2005 Jan;151(Pt 1):75-80
references: 15632427
references: Antimicrob Agents Chemother. 2000 Jul;44(7):1818-24
references: 10858336
references: Mol Microbiol. 1998 Oct;30(2):295-304
references: 9791175
references: Appl Environ Microbiol. 2006 Jan;72(1):819-25
references: 16391123
references: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5157-62
references: 17360388
references: Infect Immun. 2006 Feb;74(2):1233-42
references: 16428773
references: J Biol Chem. 2003 Feb 28;278(9):7310-9
references: 12473649
references: Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19737-42
references: 22106284
references: Curr Protoc Microbiol. 2007 Jun;Chapter 10:Unit 10A.3
references: 18770604
references: Appl Environ Microbiol. 2004 Feb;70(2):1097-103
references: 14766593
references: JAMA. 1978 Jul 7;240(1):30-4
references: 96277
references: J Bacteriol. 2000 Jun;182(12):3394-9
references: 10852869
references: Mol Microbiol. 1998 May;28(3):449-61
references: 9632250
references: Biochim Biophys Acta. 2005 Sep 15;1715(2):71-80
references: 16125133
references: Methods Enzymol. 1999;310:20-42
references: 10547780
references: Biotechnol Bioeng. 1996 Jan 5;49(1):93-100
references: 18623558
references: Antimicrob Agents Chemother. 1993 Dec;37(12):2522-6
references: 8109913
references: Science. 2011 Nov 18;334(6058):982-6
references: 22096200
references: J Exp Med. 1956 Nov 1;104(5):737-62
references: 13367341
references: J Bacteriol. 2010 Dec;192(23):6191-9
references: 20935098
references: Antimicrob Agents Chemother. 2007 Sep;51(9):3338-45
references: 17517834
references: Virulence. 2011 Sep-Oct;2(5):445-59
references: 21921685
references: Nature. 2007 Dec 6;450(7171):883-6
references: 18004304
references: Mol Microbiol. 2008 Jul;69(1):164-74
references: 18466296
references: FEMS Microbiol Lett. 2003 Oct 24;227(2):171-4
references: 14592705
references: Infect Immun. 1980 May;28(2):546-56
references: 6772562
references: Infect Immun. 2007 Mar;75(3):1079-88
references: 17158901
references: Microbes Infect. 2004 Sep;6(11):965-71
references: 15345226
references: Mol Microbiol. 1998 Sep;29(6):1449-58
references: 9781881
references: J Gen Microbiol. 1982 Apr;128(4):823-8
references: 7119747
references: Appl Environ Microbiol. 1994 Dec;60(12):4339-44
references: 7811074
references: Antimicrob Agents Chemother. 2002 Aug;46(8):2458-61
references: 12121918
references: Clin Microbiol Rev. 2005 Jan;18(1):81-101
references: 15653820
references: Trends Microbiol. 2005 Jan;13(1):20-6
references: 15639628
references: Mol Cell. 2000 Apr;5(4):717-27
references: 10882107
references: Dis Chest. 1956 Dec;30(6):642-8
references: 13375458
references: Cell Microbiol. 2006 May;8(5):806-14
references: 16611229
references: J Bacteriol. 2001 Oct;183(19):5718-24
references: 11544235
references: Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16630-5
references: 15546998
references: Mol Microbiol. 2004 Feb;51(3):675-90
references: 14731271
references: Mol Microbiol. 2003 Oct;50(1):15-27
references: 14507360
references: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16393-9
references: 19805310
references: Biochim Biophys Acta. 2007 Jul;1768(7):1717-26
references: 17524352
references: N Engl J Med. 1977 Dec 1;297(22):1189-97
references: 335244
references: Science. 2002 May 10;296(5570):1068-71
references: 12004118
references: Cell. 2005 Dec 2;123(5):861-73
references: 16325580
references: J Bacteriol. 2000 Mar;182(5):1374-82
references: 10671461
references: Mol Microbiol. 2009 Mar;71(5):1263-77
references: 19183278
references: Mol Microbiol. 2005 Feb;55(3):739-49
references: 15661000
references: Prog Lipid Res. 2012 Oct;51(4):325-39
references: 22659327
references: J Bacteriol. 2003 Mar;185(5):1485-91
references: 12591863
references: Infect Immun. 2001 Jul;69(7):4195-201
references: 11401954
references: J Biol Chem. 2010 Jun 4;285(23):17380-9
references: 20375425
references: Antimicrob Agents Chemother. 1992 Sep;36(9):2054-6
references: 1416900
references: Mol Microbiol. 2000 May;36(3):630-7
references: 10844652
references: Mol Microbiol. 2006 Sep;61(5):1196-210
references: 16925554
references: J Antimicrob Chemother. 1988 Dec;22(6):777-80
references: 3072331
references: Science. 2003 Jul 4;301(5629):105-7
references: 12843396
references: Science. 1999 May 21;284(5418):1318-22
references: 10334980
references: Biochemistry (Mosc). 2005 Feb;70(2):267-74
references: 15807669
references: FEMS Microbiol Ecol. 2011 Jul;77(1):83-94
references: 21395624
references: PLoS Pathog. 2007 May 4;3(5):e62
references: 17480118
references: J Bacteriol. 2007 Jul;189(13):4920-31
references: 17468240